File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/S0168-8278(12)60300-6
- WOS: WOS:000303241300286
- Find via
Supplementary
-
Citations:
- Web of Science: 0
- Appears in Collections:
Conference Paper: Monoclonal antibody against cadherin-17 as a potential treatment for liver cancer
| Title | Monoclonal antibody against cadherin-17 as a potential treatment for liver cancer |
|---|---|
| Authors | |
| Keywords | Medical sciences Gastroenterology |
| Issue Date | 2012 |
| Publisher | Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep |
| Citation | The 47th Annual Meeting of the European Association for the Study of the Liver (International Liver Congress™ 2012), Barcelona, Spain, 18-22 April 2012. In Journal of Hepatology, 2012 , v. 56 suppl. 2, p. S118-S119, abstract no. 287 How to Cite? |
| Abstract | BACKGROUND AND AIMS: Hepatocellular carcinoma (HCC) is a major type of liver cancer associated with high mortality. Prognosis is poor in HCC patients largely because of late diagnosis and limitations in treatment options. Therefore, this study aims to identify alternative target for HCC in hope to offer new treatments to patients. Cadherin-17 (CDH17) has been identified as an oncofetal molecule of HCC and that a suppression of its expression by RNA interference (RNAi) leads to anti-tumorigenesis. To supplement the drawbacks associated with the use of RNAi approach in biotherapy, we developed specific antibody against CDH17 for achieving similar purpose. METHODS: Hybridoma cell clones capable of secreting antibodies ... |
| Description | This journal suppl. entitled: Abstracts of The International Liver Congress™ 2012 – 47th annual meeting of the European Association for the Study of the Liver / Poster Abstracts |
| Persistent Identifier | http://hdl.handle.net/10722/165653 |
| ISSN | 2021 Impact Factor: 30.083 2020 SCImago Journal Rankings: 7.112 |
| ISI Accession Number ID |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Lee, NP | - |
| dc.contributor.author | Wang, Y | - |
| dc.contributor.author | Luk, JM | - |
| dc.date.accessioned | 2012-09-20T08:21:41Z | - |
| dc.date.available | 2012-09-20T08:21:41Z | - |
| dc.date.issued | 2012 | - |
| dc.identifier.citation | The 47th Annual Meeting of the European Association for the Study of the Liver (International Liver Congress™ 2012), Barcelona, Spain, 18-22 April 2012. In Journal of Hepatology, 2012 , v. 56 suppl. 2, p. S118-S119, abstract no. 287 | - |
| dc.identifier.issn | 0168-8278 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/165653 | - |
| dc.description | This journal suppl. entitled: Abstracts of The International Liver Congress™ 2012 – 47th annual meeting of the European Association for the Study of the Liver / Poster Abstracts | - |
| dc.description.abstract | BACKGROUND AND AIMS: Hepatocellular carcinoma (HCC) is a major type of liver cancer associated with high mortality. Prognosis is poor in HCC patients largely because of late diagnosis and limitations in treatment options. Therefore, this study aims to identify alternative target for HCC in hope to offer new treatments to patients. Cadherin-17 (CDH17) has been identified as an oncofetal molecule of HCC and that a suppression of its expression by RNA interference (RNAi) leads to anti-tumorigenesis. To supplement the drawbacks associated with the use of RNAi approach in biotherapy, we developed specific antibody against CDH17 for achieving similar purpose. METHODS: Hybridoma cell clones capable of secreting antibodies ... | - |
| dc.language | eng | - |
| dc.publisher | Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep | - |
| dc.relation.ispartof | Journal of Hepatology | - |
| dc.rights | NOTICE: this is the author’s version of a work that was accepted for publication in Journal of Hepatology. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Journal of Hepatology, v. 56, suppl. 2 (April 2012). DOI: 10.1016/S0168-8278(12)60300-6 | - |
| dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
| dc.subject | Medical sciences | - |
| dc.subject | Gastroenterology | - |
| dc.title | Monoclonal antibody against cadherin-17 as a potential treatment for liver cancer | - |
| dc.type | Conference_Paper | - |
| dc.identifier.email | Lee, NP: nikkilee@hku.hk | - |
| dc.identifier.email | Luk, JM: jmluk@hku.hk | - |
| dc.identifier.authority | Lee, NP=rp00263 | - |
| dc.identifier.authority | Luk, JM=rp00349 | - |
| dc.description.nature | postprint | - |
| dc.identifier.doi | 10.1016/S0168-8278(12)60300-6 | - |
| dc.identifier.hkuros | 211326 | - |
| dc.identifier.volume | 56 | - |
| dc.identifier.issue | suppl. 2 | - |
| dc.identifier.spage | S118, abstract no. 287 | - |
| dc.identifier.epage | S119 | - |
| dc.identifier.isi | WOS:000303241300286 | - |
| dc.publisher.place | The Netherlands | - |
| dc.identifier.issnl | 0168-8278 | - |